Zobrazeno 1 - 10
of 947
pro vyhledávání: '"van Heerden, M"'
Autor:
Vens, C., van Luijk, P., Vogelius, R.I., El Naqa, I., Humbert-Vidan, L., von Neubeck, C., Gomez-Roman, N., Bahn, E., Brualla, L., Böhlen, T.T., Ecker, S., Koch, R., Handeland, A., Pereira, S., Possenti, L., Rancati, T., Todor, D., Vanderstraeten, B., Van Heerden, M., Ullrich, W., Jackson, M., Alber, M., Marignol, L.
Publikováno v:
In Radiotherapy and Oncology July 2024 196
Autor:
van Hoogland-van Heerden, M, Böhmer, LH, Heyneke, O, Lechaba, T, Scott, L, Norton, G, Woodiwiss, A, Mntla, P, Majane, OHI
Publikováno v:
In IJC Heart & Vasculature June 2024 52
Autor:
Bharuthram, S1 sbharuthram@uwc.ac.za, van Heerden, M1
Publikováno v:
Innovations in Education & Teaching International. Jun2023, Vol. 60 Issue 3, p379-389. 11p. 1 Diagram.
Autor:
Albertini F; Center for Proton Therapy- Paul Scherrer Institute, Villigen, Switzerland., Czerska K; Center for Proton Therapy- Paul Scherrer Institute, Villigen, Switzerland., Vazquez M; Center for Proton Therapy- Paul Scherrer Institute, Villigen, Switzerland., Andaca I; Center for Proton Therapy- Paul Scherrer Institute, Villigen, Switzerland., Bachtiary B; Center for Proton Therapy- Paul Scherrer Institute, Villigen, Switzerland., Besson R; Center for Proton Therapy- Paul Scherrer Institute, Villigen, Switzerland., Bolsi A; Center for Proton Therapy- Paul Scherrer Institute, Villigen, Switzerland., Bogaert A; Center for Proton Therapy- Paul Scherrer Institute, Villigen, Switzerland., Choulilitsa E; Center for Proton Therapy- Paul Scherrer Institute, Villigen, Switzerland.; Department of Physics, ETH Zurich, Zurich, Switzerland., Hrbacek J; Center for Proton Therapy- Paul Scherrer Institute, Villigen, Switzerland., Jakobsen S; Center for Proton Therapy- Paul Scherrer Institute, Villigen, Switzerland., Leiser D; Center for Proton Therapy- Paul Scherrer Institute, Villigen, Switzerland., Matter M; Center for Proton Therapy- Paul Scherrer Institute, Villigen, Switzerland., Mayor A; Center for Proton Therapy- Paul Scherrer Institute, Villigen, Switzerland., Meier G; Center for Proton Therapy- Paul Scherrer Institute, Villigen, Switzerland., Nanz A; Center for Proton Therapy- Paul Scherrer Institute, Villigen, Switzerland., Nenoff L; Center for Proton Therapy- Paul Scherrer Institute, Villigen, Switzerland., Oxley D; Center for Proton Therapy- Paul Scherrer Institute, Villigen, Switzerland., Siewert D; Center for Proton Therapy- Paul Scherrer Institute, Villigen, Switzerland., Rohrer Schnidrig BA; Center for Proton Therapy- Paul Scherrer Institute, Villigen, Switzerland., Smolders A; Center for Proton Therapy- Paul Scherrer Institute, Villigen, Switzerland.; Department of Physics, ETH Zurich, Zurich, Switzerland., Szweda H; Center for Proton Therapy- Paul Scherrer Institute, Villigen, Switzerland., Van Heerden M; Center for Proton Therapy- Paul Scherrer Institute, Villigen, Switzerland., Winterhalter C; Center for Proton Therapy- Paul Scherrer Institute, Villigen, Switzerland., Lomax AJ; Center for Proton Therapy- Paul Scherrer Institute, Villigen, Switzerland.; Department of Physics, ETH Zurich, Zurich, Switzerland., Weber DC; Center for Proton Therapy- Paul Scherrer Institute, Villigen, Switzerland.; Department of Radiation Oncology, University Hospital Bern, Bern, Switzerland.
Publikováno v:
Physics in medicine and biology [Phys Med Biol] 2024 Nov 11; Vol. 69 (21). Date of Electronic Publication: 2024 Nov 11.
Autor:
Meijers A; Center for Proton Therapy, Paul Scherrer Institut, Forschungsstrasse 111, Villigen, 5232, Switzerland. arturs.meijers@psi.ch., Daartz J; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Knopf AC; Institute for Medical Engineering and Medical Informatics, School of Life Science FHNW, Muttenz, Switzerland.; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany., van Heerden M; Center for Proton Therapy, Paul Scherrer Institut, Forschungsstrasse 111, Villigen, 5232, Switzerland., Bizzocchi N; Center for Proton Therapy, Paul Scherrer Institut, Forschungsstrasse 111, Villigen, 5232, Switzerland., Vazquez MV; Center for Proton Therapy, Paul Scherrer Institut, Forschungsstrasse 111, Villigen, 5232, Switzerland., Bachtiary B; Center for Proton Therapy, Paul Scherrer Institut, Forschungsstrasse 111, Villigen, 5232, Switzerland., Pica A; Center for Proton Therapy, Paul Scherrer Institut, Forschungsstrasse 111, Villigen, 5232, Switzerland., Shih HA; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA., Weber DC; Center for Proton Therapy, Paul Scherrer Institut, Forschungsstrasse 111, Villigen, 5232, Switzerland.; Department of Radiation Oncology, University Hospital of Zürich, Zürich, Switzerland.; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Publikováno v:
Radiation oncology (London, England) [Radiat Oncol] 2024 Jun 17; Vol. 19 (1), pp. 75. Date of Electronic Publication: 2024 Jun 17.
Publikováno v:
Review of Social Economy, 2016 Mar 01. 74(1), 33-52.
Externí odkaz:
http://www.jstor.org/stable/26098386
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
García-Marqueta M; Center for Proton Therapy, Paul Scherrer Institute, ETH Domain, 5232 Villigen, Switzerland., Vázquez M; Center for Proton Therapy, Paul Scherrer Institute, ETH Domain, 5232 Villigen, Switzerland., Krcek R; Center for Proton Therapy, Paul Scherrer Institute, ETH Domain, 5232 Villigen, Switzerland.; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, 3012 Bern, Switzerland., Kliebsch UL; Center for Proton Therapy, Paul Scherrer Institute, ETH Domain, 5232 Villigen, Switzerland., Baust K; Department of Pediatric Hematology and Oncology, University Hospital Bonn, 53127 Bonn, Germany., Leiser D; Center for Proton Therapy, Paul Scherrer Institute, ETH Domain, 5232 Villigen, Switzerland., van Heerden M; Center for Proton Therapy, Paul Scherrer Institute, ETH Domain, 5232 Villigen, Switzerland., Pica A; Center for Proton Therapy, Paul Scherrer Institute, ETH Domain, 5232 Villigen, Switzerland., Calaminus G; Department of Pediatric Hematology and Oncology, University Hospital Bonn, 53127 Bonn, Germany., Weber DC; Center for Proton Therapy, Paul Scherrer Institute, ETH Domain, 5232 Villigen, Switzerland.; Department of Radiation Oncology, Inselspital, Bern University Hospital, University of Bern, 3012 Bern, Switzerland.; Department of Radiation Oncology, University of Zürich, 8091 Zürich, Switzerland.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Sep 06; Vol. 15 (18). Date of Electronic Publication: 2023 Sep 06.
Autor:
Kourula S; Preclinical Sciences & Translational Safety, Janssen R&D, Turnhoutseweg 30, 2340, Beerse, Belgium. Electronic address: skourula@its.jnj.com., Derksen M; HUB Organoids, Yalelaan 62, 3584 CM Utrecht, The Netherlands., Jardi F; Preclinical Sciences & Translational Safety, Janssen R&D, Turnhoutseweg 30, 2340, Beerse, Belgium., Jonkers S; Preclinical Sciences & Translational Safety, Janssen R&D, Turnhoutseweg 30, 2340, Beerse, Belgium., van Heerden M; Preclinical Sciences & Translational Safety, Janssen R&D, Turnhoutseweg 30, 2340, Beerse, Belgium., Verboven P; Preclinical Sciences & Translational Safety, Janssen R&D, Turnhoutseweg 30, 2340, Beerse, Belgium., Theuns V; Preclinical Sciences & Translational Safety, Janssen R&D, Turnhoutseweg 30, 2340, Beerse, Belgium., Van Asten S; Preclinical Sciences & Translational Safety, Janssen R&D, Turnhoutseweg 30, 2340, Beerse, Belgium., Huybrechts T; Preclinical Sciences & Translational Safety, Janssen R&D, Turnhoutseweg 30, 2340, Beerse, Belgium., Kunze A; Preclinical Sciences & Translational Safety, Janssen R&D, Turnhoutseweg 30, 2340, Beerse, Belgium., Frazer-Mendelewska E; HUB Organoids, Yalelaan 62, 3584 CM Utrecht, The Netherlands., Lai KW; HUB Organoids, Yalelaan 62, 3584 CM Utrecht, The Netherlands., Overmeer R; HUB Organoids, Yalelaan 62, 3584 CM Utrecht, The Netherlands., Roos JL; HUB Organoids, Yalelaan 62, 3584 CM Utrecht, The Netherlands., Vries RGJ; HUB Organoids, Yalelaan 62, 3584 CM Utrecht, The Netherlands., Boj SF; HUB Organoids, Yalelaan 62, 3584 CM Utrecht, The Netherlands., Monshouwer M; Preclinical Sciences & Translational Safety, Janssen R&D, Turnhoutseweg 30, 2340, Beerse, Belgium., Pourfarzad F; HUB Organoids, Yalelaan 62, 3584 CM Utrecht, The Netherlands., Snoeys J; Preclinical Sciences & Translational Safety, Janssen R&D, Turnhoutseweg 30, 2340, Beerse, Belgium.
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences [Eur J Pharm Sci] 2023 Sep 01; Vol. 188, pp. 106481. Date of Electronic Publication: 2023 May 25.